HEADER HYDROLASE 08-FEB-05 2BJU TITLE PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN II; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 5 EC: 3.4.23.39; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 5833; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PLASMEPSIN, ASPARTIC PROTEINASE, DRUG DESIGN, MALARIA, KEYWDS 2 ASPARTYL PROTEASE, GLYCOPROTEIN, HYDROLASE, SIGNAL, KEYWDS 3 ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR L.PRADE,A.F.JONES,C.BOSS,S.RICHARDS-BILDSTEIN,S.MEYER, AUTHOR 2 C.BINKERT,D.BUR REVDAT 5 24-FEB-09 2BJU 1 VERSN REVDAT 4 05-JUL-05 2BJU 1 AUTHOR REVDAT 3 22-JUN-05 2BJU 1 JRNL REVDAT 2 27-APR-05 2BJU 1 JRNL REVDAT 1 18-APR-05 2BJU 0 JRNL AUTH L.PRADE,A.F.JONES,C.BOSS,S.RICHARD-BILDSTEIN, JRNL AUTH 2 S.MEYER,C.BINKERT,D.BUR JRNL TITL X-RAY STRUCTURE OF PLASMEPSIN II COMPLEXED WITH A JRNL TITL 2 POTENT ACHIRAL INHIBITOR. JRNL REF J.BIOL.CHEM. V. 280 23837 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15840589 JRNL DOI 10.1074/JBC.M501519200 REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 158.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 53895 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2885 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.56 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.60 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3297 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE SET COUNT : 186 REMARK 3 BIN FREE R VALUE : 0.3650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2642 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 381 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.34000 REMARK 3 B22 (A**2) : -0.98000 REMARK 3 B33 (A**2) : -0.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.088 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.052 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2819 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3841 ; 1.447 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 338 ; 6.550 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 415 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2150 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1352 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 308 ; 0.153 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 43 ; 0.259 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 36 ; 0.251 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1666 ; 1.707 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2720 ; 2.786 ; 4.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1153 ; 2.130 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1121 ; 3.244 ; 4.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2BJU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-05. REMARK 100 THE PDBE ID CODE IS EBI-22881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60622 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 157.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.26000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.97200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 78.57100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.97200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 78.57100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYTIC ACTIVITY: HYDROLYSIS OF THE BONDS LINKING REMARK 400 CERTAIN HYDROPHOBIC RESIDUES IN GLOBIN AND HEMOGLOBIN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -124 REMARK 465 ASP A -123 REMARK 465 ILE A -122 REMARK 465 THR A -121 REMARK 465 VAL A -120 REMARK 465 ARG A -119 REMARK 465 GLU A -118 REMARK 465 HIS A -117 REMARK 465 ASP A -116 REMARK 465 PHE A -115 REMARK 465 LYS A -114 REMARK 465 HIS A -113 REMARK 465 GLY A -112 REMARK 465 PHE A -111 REMARK 465 ILE A -110 REMARK 465 LYS A -109 REMARK 465 SER A -108 REMARK 465 ASN A -107 REMARK 465 SER A -106 REMARK 465 THR A -105 REMARK 465 PHE A -104 REMARK 465 ASP A -103 REMARK 465 GLY A -102 REMARK 465 LEU A -101 REMARK 465 ASN A -100 REMARK 465 ILE A -99 REMARK 465 ASP A -98 REMARK 465 ASN A -97 REMARK 465 SER A -96 REMARK 465 LYS A -95 REMARK 465 ASN A -94 REMARK 465 LYS A -93 REMARK 465 LYS A -92 REMARK 465 LYS A -91 REMARK 465 ILE A -90 REMARK 465 GLN A -89 REMARK 465 LYS A -88 REMARK 465 GLY A -87 REMARK 465 PHE A -86 REMARK 465 GLN A -85 REMARK 465 ILE A -84 REMARK 465 LEU A -83 REMARK 465 TYR A -82 REMARK 465 VAL A -81 REMARK 465 LEU A -80 REMARK 465 LEU A -79 REMARK 465 PHE A -78 REMARK 465 CYS A -77 REMARK 465 SER A -76 REMARK 465 VAL A -75 REMARK 465 MET A -74 REMARK 465 CYS A -73 REMARK 465 GLY A -72 REMARK 465 LEU A -71 REMARK 465 PHE A -70 REMARK 465 TYR A -69 REMARK 465 TYR A -68 REMARK 465 VAL A -67 REMARK 465 TYR A -66 REMARK 465 GLU A -65 REMARK 465 ASN A -64 REMARK 465 VAL A -63 REMARK 465 TRP A -62 REMARK 465 LEU A -61 REMARK 465 GLN A -60 REMARK 465 ARG A -59 REMARK 465 ASP A -58 REMARK 465 ASN A -57 REMARK 465 GLU A -56 REMARK 465 MET A -55 REMARK 465 ASN A -54 REMARK 465 GLU A -53 REMARK 465 ILE A -52 REMARK 465 LEU A -51 REMARK 465 LYS A -50 REMARK 465 ASN A -49 REMARK 465 SER A -48 REMARK 465 GLU A -47 REMARK 465 HIS A -46 REMARK 465 LEU A -45 REMARK 465 THR A -44 REMARK 465 ILE A -43 REMARK 465 GLY A -42 REMARK 465 PHE A -41 REMARK 465 LYS A -40 REMARK 465 VAL A -39 REMARK 465 GLU A -38 REMARK 465 ASN A -37 REMARK 465 ALA A -36 REMARK 465 HIS A -35 REMARK 465 ASP A -34 REMARK 465 ARG A -33 REMARK 465 ILE A -32 REMARK 465 LEU A -31 REMARK 465 LYS A -30 REMARK 465 THR A -29 REMARK 465 ILE A -28 REMARK 465 LYS A -27 REMARK 465 THR A -26 REMARK 465 HIS A -25 REMARK 465 LYS A -24 REMARK 465 LEU A -23 REMARK 465 LYS A -22 REMARK 465 ASN A -21 REMARK 465 TYR A -20 REMARK 465 ILE A -19 REMARK 465 LYS A -18 REMARK 465 GLU A -17 REMARK 465 SER A -16 REMARK 465 VAL A -15 REMARK 465 ASN A -14 REMARK 465 PHE A -13 REMARK 465 LEU A -12 REMARK 465 ASN A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 LEU A -8 REMARK 465 THR A -7 REMARK 465 LYS A -6 REMARK 465 THR A -5 REMARK 465 ASN A -4 REMARK 465 TYR A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 1 - O HOH A 2005 2.16 REMARK 500 OG SER A 2 - O HOH A 2012 1.69 REMARK 500 O GLY A 216 - O HOH A 2284 2.10 REMARK 500 O LEU A 234 - O HOH A 2294 1.84 REMARK 500 O27 IH4 A 1331 - O HOH A 2381 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 162 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP A 190 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 2 -159.39 56.87 REMARK 500 ASN A 3 165.39 71.36 REMARK 500 ALA A 38 23.85 -145.40 REMARK 500 TYR A 77 -95.57 -89.36 REMARK 500 LYS A 163 -54.00 -123.86 REMARK 500 LEU A 191 -89.90 -143.61 REMARK 500 ASN A 251 105.51 -58.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IH4 A1330 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IH4 A1331 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J8J RELATED DB: PDB REMARK 900 A NEW CLASS OF SMALL NON-PEPTIDYL REMARK 900 COMPOUNDS BLOCKSPLASMODIUM FALCIPARUM DEVELOPMENT REMARK 900 IN VITRO BY INHIBITINGPLASMEPSINS REMARK 900 RELATED ID: 1LEE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. REMARK 900 FALCIPARUM INCOMPLEX WITH INHIBITOR RS367 REMARK 900 RELATED ID: 1LF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P REMARK 900 FALCIPARUM INCOMPLEX WITH INHIBITOR RS370 REMARK 900 RELATED ID: 1LF3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P REMARK 900 FALCIPARUM INCOMPLEX WITH INHIBITOR EH58 REMARK 900 RELATED ID: 1LF4 RELATED DB: PDB REMARK 900 STRUCTURE OF PLASMEPSIN II REMARK 900 RELATED ID: 1M43 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH REMARK 900 PEPSTATIN A TO2.4 A REMARK 900 RELATED ID: 1ME6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II, AN REMARK 900 ASPARTYL PROTEASEFROM PLASMODIUM FALCIPARUM, IN REMARK 900 COMPLEX WITH A STATINE-BASED INHIBITOR REMARK 900 RELATED ID: 1PFZ RELATED DB: PDB REMARK 900 PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM REMARK 900 RELATED ID: 1SME RELATED DB: PDB REMARK 900 PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME REMARK 900 FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH REMARK 900 PEPSTATIN A REMARK 900 RELATED ID: 1W6H RELATED DB: PDB REMARK 900 NOVEL PLASMEPSIN II-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1W6I RELATED DB: PDB REMARK 900 PLASMEPSIN II-PEPSTATIN A COMPLEX DBREF 2BJU A -124 -1 UNP P46925 PLM2_PLAFA 1 124 DBREF 2BJU A 1 329 UNP P46925 PLM2_PLAFA 125 453 SEQRES 1 A 453 MET ASP ILE THR VAL ARG GLU HIS ASP PHE LYS HIS GLY SEQRES 2 A 453 PHE ILE LYS SER ASN SER THR PHE ASP GLY LEU ASN ILE SEQRES 3 A 453 ASP ASN SER LYS ASN LYS LYS LYS ILE GLN LYS GLY PHE SEQRES 4 A 453 GLN ILE LEU TYR VAL LEU LEU PHE CYS SER VAL MET CYS SEQRES 5 A 453 GLY LEU PHE TYR TYR VAL TYR GLU ASN VAL TRP LEU GLN SEQRES 6 A 453 ARG ASP ASN GLU MET ASN GLU ILE LEU LYS ASN SER GLU SEQRES 7 A 453 HIS LEU THR ILE GLY PHE LYS VAL GLU ASN ALA HIS ASP SEQRES 8 A 453 ARG ILE LEU LYS THR ILE LYS THR HIS LYS LEU LYS ASN SEQRES 9 A 453 TYR ILE LYS GLU SER VAL ASN PHE LEU ASN SER GLY LEU SEQRES 10 A 453 THR LYS THR ASN TYR LEU GLY SER SER ASN ASP ASN ILE SEQRES 11 A 453 GLU LEU VAL ASP PHE GLN ASN ILE MET PHE TYR GLY ASP SEQRES 12 A 453 ALA GLU VAL GLY ASP ASN GLN GLN PRO PHE THR PHE ILE SEQRES 13 A 453 LEU ASP THR GLY SER ALA ASN LEU TRP VAL PRO SER VAL SEQRES 14 A 453 LYS CYS THR THR ALA GLY CYS LEU THR LYS HIS LEU TYR SEQRES 15 A 453 ASP SER SER LYS SER ARG THR TYR GLU LYS ASP GLY THR SEQRES 16 A 453 LYS VAL GLU MET ASN TYR VAL SER GLY THR VAL SER GLY SEQRES 17 A 453 PHE PHE SER LYS ASP LEU VAL THR VAL GLY ASN LEU SER SEQRES 18 A 453 LEU PRO TYR LYS PHE ILE GLU VAL ILE ASP THR ASN GLY SEQRES 19 A 453 PHE GLU PRO THR TYR THR ALA SER THR PHE ASP GLY ILE SEQRES 20 A 453 LEU GLY LEU GLY TRP LYS ASP LEU SER ILE GLY SER VAL SEQRES 21 A 453 ASP PRO ILE VAL VAL GLU LEU LYS ASN GLN ASN LYS ILE SEQRES 22 A 453 GLU ASN ALA LEU PHE THR PHE TYR LEU PRO VAL HIS ASP SEQRES 23 A 453 LYS HIS THR GLY PHE LEU THR ILE GLY GLY ILE GLU GLU SEQRES 24 A 453 ARG PHE TYR GLU GLY PRO LEU THR TYR GLU LYS LEU ASN SEQRES 25 A 453 HIS ASP LEU TYR TRP GLN ILE THR LEU ASP ALA HIS VAL SEQRES 26 A 453 GLY ASN ILE MET LEU GLU LYS ALA ASN CYS ILE VAL ASP SEQRES 27 A 453 SER GLY THR SER ALA ILE THR VAL PRO THR ASP PHE LEU SEQRES 28 A 453 ASN LYS MET LEU GLN ASN LEU ASP VAL ILE LYS VAL PRO SEQRES 29 A 453 PHE LEU PRO PHE TYR VAL THR LEU CYS ASN ASN SER LYS SEQRES 30 A 453 LEU PRO THR PHE GLU PHE THR SER GLU ASN GLY LYS TYR SEQRES 31 A 453 THR LEU GLU PRO GLU TYR TYR LEU GLN HIS ILE GLU ASP SEQRES 32 A 453 VAL GLY PRO GLY LEU CYS MET LEU ASN ILE ILE GLY LEU SEQRES 33 A 453 ASP PHE PRO VAL PRO THR PHE ILE LEU GLY ASP PRO PHE SEQRES 34 A 453 MET ARG LYS TYR PHE THR VAL PHE ASP TYR ASP ASN HIS SEQRES 35 A 453 SER VAL GLY ILE ALA LEU ALA LYS LYS ASN LEU HET IH4 A1330 44 HET IH4 A1331 44 HETNAM IH4 N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL) HETSYN IH4 INHIBITOR OF PLASMEPSIN II FORMUL 2 IH4 2(C37 H44 N4 O3) FORMUL 4 HOH *381(H2 O1) HELIX 1 1 GLY A 51 LYS A 55 5 5 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 PRO A 113 SER A 118 1 6 HELIX 5 5 TRP A 128 SER A 132 5 5 HELIX 6 6 PRO A 138 GLN A 146 1 9 HELIX 7 7 GLU A 174 ARG A 176 5 3 HELIX 8 8 PRO A 223 LEU A 231 1 9 HELIX 9 9 GLU A 269 TYR A 273 1 5 HELIX 10 10 GLY A 302 LYS A 308 1 7 SHEET 1 AA 3 GLU A 67 ASN A 76 0 SHEET 2 AA 3 THR A 81 VAL A 93 -1 O VAL A 82 N MET A 75 SHEET 3 AA 3 MET A 15 VAL A 22 -1 O GLU A 21 N THR A 92 SHEET 1 AB 7 GLU A 67 ASN A 76 0 SHEET 2 AB 7 THR A 81 VAL A 93 -1 O VAL A 82 N MET A 75 SHEET 3 AB 7 LEU A 96 ASP A 107 -1 O LEU A 96 N VAL A 93 SHEET 4 AB 7 LEU A 40 PRO A 43 1 O LEU A 40 N ILE A 103 SHEET 5 AB 7 GLY A 122 GLY A 125 -1 O ILE A 123 N TRP A 41 SHEET 6 AB 7 GLN A 27 ASP A 34 1 O ILE A 32 N LEU A 124 SHEET 7 AB 7 MET A 15 VAL A 22 -1 O GLY A 18 N PHE A 31 SHEET 1 AC 4 ILE A 237 LYS A 238 0 SHEET 2 AC 4 TYR A 245 LEU A 248 -1 O VAL A 246 N ILE A 237 SHEET 3 AC 4 LEU A 284 LEU A 287 -1 O CYS A 285 N THR A 247 SHEET 4 AC 4 LEU A 274 HIS A 276 -1 O GLN A 275 N MET A 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.03 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.04 CISPEP 1 GLU A 112 PRO A 113 0 -1.37 CISPEP 2 GLN A 232 ASN A 233 0 -6.72 SITE 1 AC1 20 ILE A 14 MET A 15 ILE A 32 ASP A 34 SITE 2 AC1 20 MET A 75 TYR A 77 PHE A 111 TYR A 115 SITE 3 AC1 20 SER A 118 ASP A 121 TYR A 192 ASP A 214 SITE 4 AC1 20 GLY A 216 THR A 217 ILE A 300 IH4 A1331 SITE 5 AC1 20 HOH A2284 HOH A2377 HOH A2378 HOH A2379 SITE 1 AC2 17 ILE A 14 TYR A 77 THR A 114 GLY A 216 SITE 2 AC2 17 THR A 217 SER A 218 PHE A 241 PHE A 244 SITE 3 AC2 17 LEU A 287 ASN A 288 ILE A 289 LEU A 292 SITE 4 AC2 17 IH4 A1330 HOH A2186 HOH A2284 HOH A2379 SITE 5 AC2 17 HOH A2381 CRYST1 67.944 157.142 38.867 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014718 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006364 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025729 0.00000